A recent clinical study published in the November issue of Plastic and Reconstructive Surgery—the official medical journal of the American Society of Plastic Surgeons (ASPS)—has unveiled a concerning correlation between a history of COVID-19 and the incidence of life-threatening blood clots following body contouring surgery. The research specifically highlights that patients undergoing panniculectomy, a procedure to remove excess abdominal skin often performed after significant weight loss, may face a substantially higher risk of venous thromboembolism (VTE) if they have previously contracted the SARS-CoV-2 virus.
As elective surgical volumes return to pre-pandemic levels, surgeons are being urged to recalibrate their risk assessment protocols. This study, led by researchers at the Penn State College of Medicine, provides critical data that may redefine how plastic surgeons screen, prepare, and treat patients who have weathered a COVID-19 infection.
The Core Findings: A Closer Look at VTE Risk
The research, titled "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19," suggests that the physiological footprint left by COVID-19 persists long after the initial infection has cleared.
Venous thromboembolism (VTE) encompasses both deep vein thrombosis (DVT)—a clot typically occurring in the legs—and pulmonary embolism (PE), where a clot travels to the lungs. Both conditions are significant surgical complications that can be fatal if not managed immediately. While standard surgical protocols utilize the Caprini risk assessment score to determine the necessity of prophylactic anticoagulants (blood thinners), this new study suggests that the "COVID factor" may be a hidden variable that current scoring systems do not fully account for.
Lead author Mary Newland, BS, a medical student at Penn State College of Medicine, notes that the implications for body contouring surgery are profound. "Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy," Newland stated. "This may have critical implications for the assessment and prevention of surgical risks in patients who have achieved major weight loss."
Understanding the Procedure: Why Panniculectomy Matters
To understand the scope of the study, it is essential to distinguish the procedure in question. A panniculectomy is not merely a cosmetic endeavor. While it involves the removal of the "pannus"—the hanging apron of skin and fat on the lower abdomen—the procedure is frequently deemed a functional necessity.
Patients who have undergone massive weight loss often struggle with redundant skin that can lead to chronic intertrigo (rashes), severe skin infections, ulcerations, and significant mobility limitations. By removing this tissue, surgeons alleviate physical pain and prevent recurrent dermatological issues. However, because the procedure involves extensive surgical dissection, it inherently carries a risk of VTE. Ensuring the safety of these patients is paramount, particularly as the population of patients seeking post-bariatric surgery continues to grow.
Chronology of the Analysis: Data from 2017 to 2023
The research team conducted a retrospective analysis of a robust dataset involving 7,114 patients who underwent functional panniculectomy between 2017 and 2023. This timeline is significant because it provides a clear "before and after" snapshot of surgical outcomes relative to the global pandemic.
The Phases of the Study:
- The Pre-Pandemic Baseline (2017–Early 2020): The researchers identified 3,015 patients who underwent the procedure prior to the onset of the pandemic. During this period, the observed rate of VTE was 3.2%.
- The Pandemic Era (2020–2023): The researchers identified 4,099 patients who underwent the surgery after March 2020. Interestingly, the initial comparison showed that the overall rate of VTE in this group was 3.0%, appearing statistically similar to the pre-pandemic cohort.
- The COVID-Specific Stratification: The critical insight emerged when the team delved deeper into the pandemic-era group. By isolating the patients based on their COVID-19 history, the researchers were able to separate 790 patients with a known history of the virus from 3,309 patients who had never been infected.
The results of this stratification were striking. Patients with a history of COVID-19 demonstrated a VTE incidence rate of 4.9%, compared to just 2.5% in those without such a history.
Supporting Data: Examining the Hypercoagulability Hypothesis
The study controlled for other common comorbidities—such as cardiovascular disease, pulmonary conditions, and vascular disorders—finding that these factors were balanced between the two groups. This suggests that the increased risk of VTE cannot be easily dismissed as a byproduct of pre-existing health issues alone.
The authors propose that the primary culprit is "hypercoagulability," a systemic state of increased blood-clotting tendency that has been widely documented as a long-term sequela of COVID-19. SARS-CoV-2 is known to cause endothelial dysfunction—damage to the lining of the blood vessels—which creates an environment where clots are more likely to form. When this physiological predisposition is combined with the trauma of a major surgical procedure, the body’s natural clotting defenses may become overwhelmed.
This finding aligns with broader medical observations that COVID-19 is not merely a respiratory illness but a vascular one. The persistent inflammatory state often seen in "Long COVID" patients may be creating a heightened threshold for surgical safety that clinicians have yet to fully standardize.
Official Responses and Clinical Implications
The publication of this study has sparked a conversation among plastic surgeons regarding the future of pre-operative consultations. If a history of COVID-19 increases the risk of a life-threatening complication by nearly twofold, standard screening must evolve.
Potential Changes to Clinical Practice:
- Enhanced Risk Scoring: Clinicians may need to add a "COVID-19 history" modifier to the Caprini risk assessment score.
- Extended Prophylaxis: Surgeons might consider extending the duration of post-operative anticoagulation therapy for patients who have had severe or recent COVID-19 infections.
- Timing of Surgery: The study raises questions about whether there should be a "waiting period" after a COVID-19 infection before a patient is cleared for elective body contouring, similar to the guidelines often applied to other major surgeries.
"Our results demonstrate a significant increase in the incidence of VTE among panniculectomy patients with a history of COVID-19," the authors noted in their concluding remarks. While they acknowledge that other environmental and genetic factors might play a role, the data points clearly toward the infection as a primary driver of the increased risk.
Future Research and Moving Forward
While this study provides a vital piece of the puzzle, the researchers emphasize that it is not the final word. The scientific community must continue to track these outcomes to determine if the risk is tied to the severity of the initial infection, the timing of the surgery relative to the infection, or the specific variant of the virus the patient contracted.
The study concludes by calling for prospective, multi-center trials to confirm these findings. "This study shows the emergence of a new patient population who may be more susceptible to postoperative VTEs," the authors state. By recognizing this increased risk, the medical community can develop targeted interventions, ensuring that life-changing body contouring procedures remain safe and effective for the growing number of patients who have survived the pandemic.
About the Publishing Entities
- Plastic and Reconstructive Surgery: As the official journal of the American Society of Plastic Surgeons, it remains the leading peer-reviewed publication in the field, dedicated to advancing the science and practice of plastic and reconstructive surgery.
- Wolters Kluwer: A global leader in professional information and software solutions, Wolters Kluwer continues to support medical research by publishing high-impact journals that bridge the gap between complex data and clinical application. With operations in over 40 countries, the organization plays a pivotal role in disseminating research that helps healthcare professionals make critical decisions for patient safety.
For those interested in the full methodology and data tables, the full text of the study is available through the Plastic and Reconstructive Surgery portal, providing a roadmap for surgeons who seek to mitigate risk in an increasingly complex post-pandemic surgical landscape.
About the Author
